Flow and tDCS Evidence Flow Overview Flow Webinars In-clinic Resources Marketing Materials


Flow and the NHS

Flow Neuroscience's Head of Growth, Sam Lowden, alongside Flow Neuroscience's NHS Liasion Lead, Alexis Besson, provide a deep-dive into everything related to Flow and the NHS:

  • Dive into results from ongoing primary care, perinatal and CMHT pilots
  • Hear clinician and patient feedback  
  • Overview of recent NICE MIB324
  • Upcoming opportunities 
  • Open Q&A

Overview of long-term usage and Flow treatment schedules

Flow Neuroscience's Clinical Lead, Hanna Silva, shares insights about Flow's stimulation schedule and long-term usage. Specifically:

  • Overview of the Flow treatment schedule
  • What does the evidence say about long-term usage of tDCS?
  • Alternative stimulation schedule recommendations
  • Open Q&A

EMPOWER trial interim results review

Hear directly from Flow Neuroscience Chief Clinical Officer and Founder, Daniel Månsson, in an exclusive webinar to learn more about Flow's recent clinical trial. Specifically:

  • Overview and summary of the initial results from the EMPOWER clinical trial 
  • Review what these results mean for your patients and your practice